Marshall Wace, LLP Moderna, Inc. Put Options Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $13.4 Million - $19.5 Million	-99,100 Reduced 70.94%	40,600 $6.24 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2.2 Million - $3.91 Million	18,600 Added 15.36%	139,700 $25.1 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.38 Million - $2.27 Million	11,700 Added 10.69%	121,100 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $8.54 Million - $12.9 Million	72,900 Added 199.73%	109,400 $15.6 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $4.3 Million - $7.99 Million	34,000 Added 1360.0%	36,500 $6.29 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $564,550 - $921,275	2,500 New	2,500 $634,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.